ACAD
Acadia Pharmaceuticals margins
- Stocks
- Healthcare
- NASDAQ: ACAD
- Margins
The Acadia Pharmaceuticals shows a gross margin of 91.1%, an operating margin of 7.6%, an EBITDA margin of 11.7%, and a net margin of 33.4%. Net margin showed the largest year-over-year gain at 11.6 percentage points, whereas EBITDA margin showed the largest decline at 15.9 percentage points.
ACAD margin history
Over the last 3 years, Acadia Pharmaceuticals's margins averaged 91.96% gross, 11.15% operating, 15.29% EBITDA, and 18.74% net. The current figures show net margin is above its three-year average, while gross, operating, and EBITDA margins are below their three-year averages.
ACAD margin expansion
From the same period last year, net margin expanded by 11.6 percentage points, while gross margin contracted by 0.9 percentage points, operating margin by 15.6 percentage points, and EBITDA margin by 15.9 percentage points.
ACAD Gross margin
Looking at the last 3 years, Acadia Pharmaceuticals had an average gross margin of 91.96%. Against its three-year average, Acadia Pharmaceuticals's gross margin is currently 91.1%, 0.9 percentage points below its three-year average. Looking back over the last 3 years, Acadia Pharmaceuticals's gross margin reached 94.3% at its highest point in Dec 2023 and 91.1% at its lowest in Jun 2026.
ACAD Operating margin
Looking back over the last 3 years, Acadia Pharmaceuticals recorded an average operating margin of 11.15%. Acadia Pharmaceuticals's current operating margin is 7.6% and is 3.6 percentage points below its three-year average. The highest operating margin for Acadia Pharmaceuticals was 24.1% in Dec 2024, while the lowest was -10.1% in Dec 2023.
ACAD EBITDA margin
Across the last 3 years, Acadia Pharmaceuticals had an average EBITDA margin of 15.29%. Against its three-year average, Acadia Pharmaceuticals's EBITDA margin is currently 11.7%, 3.6 percentage points below its three-year average. Looking back over the last 3 years, Acadia Pharmaceuticals's EBITDA margin reached 28.6% at its highest point in Dec 2024 and -6.3% at its lowest in Dec 2023.
ACAD Net margin
Over the last 3 years, Acadia Pharmaceuticals's net margin averaged 18.74%. The current net margin of 33.4% is 14.7 percentage points above its three-year average. During this period, net margin reached a high of 36.5% in Dec 2025 and a low of -8.4% in Dec 2023.
ACAD margin group comparison
Acadia Pharmaceuticals's gross margin of 91.1% is higher than the Healthcare sector, the industry and its peers average. Looking at the Healthcare sector average of 68.3%, Acadia Pharmaceuticals's gross margin is 33% higher.
ACAD margin peer comparison
Frequently asked questions
What is Acadia Pharmaceuticals's gross margin?
As of Jun 30, 2026, ACAD has a gross margin of 91.1%.
What is Acadia Pharmaceuticals's operating margin?
For the period ending Jun 30, 2026, ACAD recorded an operating margin of 7.6%.
What is Acadia Pharmaceuticals's EBITDA margin?
The current EBITDA margin for ACAD is 11.7% as of Jun 30, 2026.
What is Acadia Pharmaceuticals's net margin?
As of Jun 30, 2026, ACAD has a net margin of 33.4%.
What are the average margins of ACAD?
Over the past 3 years, ACAD reported average margins of 92.0% gross, 11.2% operating, 15.3% EBITDA, and 18.7% net.
What are the highest historical margins of ACAD?
Looking back across 5 years, ACAD reached 98.3% gross in Mar 2023, 24.1% operating in Dec 2024, 28.6% EBITDA in Dec 2024, and 36.5% net in Dec 2025.
What are the lowest historical margins of ACAD?
Over the last 5 years, Acadia Pharmaceuticals's lowest margins were 91.1% gross in Jun 2026, -43.9% operating in Mar 2022, -42.7% EBITDA in Mar 2022, and -43.5% net in Mar 2022.